StockData
BioVie Inc. logo

BioVie Inc. (BIVI) stock

BIVINasdaqPharmaceutical PreparationsFiscal year ends June 30Also trades as BIVIW
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 5/30
$1.00−0.08 (-7.84%)

Close on Nov 17, 2026Market cap $7.51MP/E –Yield –

BioVie cash

Cash and short-term investments held at the end of each period.

BioVie's cash was $8.98M at Jun 30, 2026. For fiscal 2026 it was $8.98M, down 48.8% from the year before. Over ten years it grew 53.5% a year on average. The highest annual figure on record is $23.84M in fiscal 2024.

Annual cash

PeriodPeriod endValueChange
FY2026Jun 30, 2026$8.98M-48.8%
FY2025Jun 30, 2025$17.54M-26.4%
FY2024Jun 30, 2024$23.84M+22.5%
FY2023Jun 30, 2023$19.46M+4.4%
FY2022Jun 30, 2022$18.64M+313.2%
FY2021Jun 30, 2021$4.51M+12029.7%
FY2020Jun 30, 2020$37.20K-89.1%
FY2019Jun 30, 2019$339.92K+642.2%
FY2018Jun 30, 2018$45.80K+791.1%
FY2017Jun 30, 2017$5.14K-95.8%
FY2016Jun 30, 2016$123.76K-53.7%
FY2015Jun 30, 2015$267.48K-19.6%
FY2014Jun 30, 2014$332.86K-34.2%
FY2013Jun 30, 2013$505.70K–

Quarterly cash

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q4 FY2026CQ2 2026Jun 30, 2026$8.98M-48.8%
Q3 FY2026CQ1 2026Mar 31, 2026$13.10M-43.4%
Q2 FY2026CQ4 2025Dec 31, 2025$20.54M-15.8%
Q1 FY2026CQ3 2025Sep 30, 2025$24.98M+24.7%
Q4 FY2025CQ2 2025Jun 30, 2025$17.54M-26.4%
Q3 FY2025CQ1 2025Mar 31, 2025$23.15M-23.7%
Q2 FY2025CQ4 2024Dec 31, 2024$24.41M+20.7%
Q1 FY2025CQ3 2024Sep 30, 2024$20.02M-5.6%
Q4 FY2024CQ2 2024Jun 30, 2024$23.84M+22.5%
Q3 FY2024CQ1 2024Mar 31, 2024$30.35M-3.0%
Q2 FY2024CQ4 2023Dec 31, 2023$20.23M-55.8%
Q1 FY2024CQ3 2023Sep 30, 2023$21.21M-0.1%
Q4 FY2023CQ2 2023Jun 30, 2023$19.46M+4.4%
Q3 FY2023CQ1 2023Mar 31, 2023$31.28M+27.6%
Q2 FY2023CQ4 2022Dec 31, 2022$45.75M+50.5%
Q1 FY2023CQ3 2022Sep 30, 2022$21.23M+3.6%
Q4 FY2022CQ2 2022Jun 30, 2022$18.64M+313.2%
Q3 FY2022CQ1 2022Mar 31, 2022$24.51M+115.9%
Q2 FY2022CQ4 2021Dec 31, 2021$30.39M+81609.0%
Q1 FY2022CQ3 2021Sep 30, 2021$20.49M+55.3%
Q4 FY2021CQ2 2021Jun 30, 2021$4.51M+12029.7%
Q3 FY2021CQ1 2021Mar 31, 2021$11.35M+305452.0%
Q2 FY2021CQ4 2020Dec 31, 2020$37.20K+1096.8%
Q1 FY2021CQ3 2020Sep 30, 2020$13.20M+5199.2%
Q4 FY2020CQ2 2020Jun 30, 2020$37.20K-89.1%
Q3 FY2020CQ1 2020Mar 31, 2020$3.72K-99.6%
Q2 FY2020CQ4 2019Dec 31, 2019$3.11K-99.8%
Q1 FY2020CQ3 2019Sep 30, 2019$249.01K+443.7%
Q4 FY2019CQ2 2019Jun 30, 2019$339.92K+1110.6%
Q3 FY2019CQ1 2019Mar 31, 2019$971.61K+53168.3%
Q1 FY2019CQ3 2018Dec 31, 2018$1.63M+7412.7%
Q4 FY2018CQ2 2018Jun 30, 2018$45.80K+791.1%
Q3 FY2018CQ1 2018Mar 31, 2018$28.08K-20.5%
Q2 FY2018CQ4 2017Dec 31, 2017$1.82K-59.6%
Q1 FY2018CQ3 2017Sep 30, 2017$21.70K+148.2%
Q4 FY2017CQ2 2017Jun 30, 2017$5.14K-95.8%
Q3 FY2017CQ1 2017Mar 31, 2017$35.31K–
Q2 FY2017CQ4 2016Dec 31, 2016$4.52K–
Q1 FY2017CQ3 2016Sep 30, 2016$8.75K–
Q4 FY2016CQ2 2016Jun 30, 2016$123.76K–

More BioVie figures

See a number that looks wrong?